Primary information |
---|
ID | antitb_1541, |
Name | 25613372 |
N-Terminal modification | RNase3 |
C-Terminal Modification | RPPQFTRAQWFAIQHISLMPPRCTIAMRAINNYRWRCKNQNTFLR |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 45 |
Source | L |
Origin | Cationic |
Species | Protein derived |
Strain | Derived from eisinophilic cationic protein (ECP) |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC = 20 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Bactericidal against pseudomonas and staphylococcus at pH 5.5 |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1542, |
Name | 25613372 |
N-Terminal modification | RNAse7 |
C-Terminal Modification | RPPQFTRAQWFAIQHISLMPPRCTIAMRAINNYRWRCKNQNTFLR |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 45 |
Source | L |
Origin | Cationic |
Species | Protein derived |
Strain | Derived from eisinophilic cationic protein (ECP) |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC = 10 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Bactericidal against pseudomonas and staphylococcus at pH 5.5 |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1543, |
Name | 25613372 |
N-Terminal modification | RNAse7 |
C-Terminal Modification | RPPQFTRAQWFAIQHISLMPPRCTIAMRAINNYRWRCKNQNTFLR |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 45 |
Source | L |
Origin | Cationic |
Species | Protein derived |
Strain | Derived from eisinophilic cationic protein (ECP) |
Inhibition Concentration | Mycobacterium vaccae |
In Vitro/ In vivo | Mycobacterium vaccae |
Cell Line | MIC = 10 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | NA |
Year of Publication | Bactericidal against pseudomonas and staphylococcus at pH 5.5 |
Tertiary Structure (Technique) | Not Predicted), |